These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study. De Vecchi AF, Kopple JD, Young GA, Nolph KD, Vonesh EF, Castelnovo C, Dichiro J, Nissenson A, Brownjohn AM, Prowant B. Am J Nephrol; 1990; 10(6):451-6. PubMed ID: 2075902 [Abstract] [Full Text] [Related]
11. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis? Fiedler R, Schneider I, Fischer K, Deuber HJ, Osten B. Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267 [Abstract] [Full Text] [Related]
12. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD). Lamperi S, Carozzi S. Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740 [Abstract] [Full Text] [Related]
14. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis. Howard RL, Millspaugh J, Teitelbaum I. Am J Kidney Dis; 1990 Nov; 16(5):469-72. PubMed ID: 2239939 [Abstract] [Full Text] [Related]
15. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Chuang YW, Shu KH, Yu TM, Cheng CH, Chen CH. Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738 [Abstract] [Full Text] [Related]